Table 1.
Clinicopathological data of male glioblastoma (GBM) patients from southeast Sweden.
| Characteristics | Category | Number of Patients | Percentage |
|---|---|---|---|
| Age, years | ≤60 | 64 | 61% |
| >60 | 41 | 39% | |
| Surgery | Biopsy | 15 | 14% |
| Partial resection | 24 | 23% | |
| Large total resection | 66 | 63% | |
| Preoperative performance status WHO | 0–1 | 83 | 79% |
| 2–3 | 19 | 18% | |
| Missing | 3 | 3% | |
| RT dose (Gray) | 34 a | 7 | 6.7% |
| 40–50 b | 8 | 7.6% | |
| 54–60 | 89 | 84.7% | |
| Missing | 1 | 1% | |
| MGMT | Methylated | 36 | 65.7% |
| Unmethylated | 69 | 34.3% | |
| SRY CN | ≤0.6 | 12 | 11.4% |
| >0.6 | 92 | 87.6% | |
| Missing | 1 | 0.95% |
a Hypofractionated 3.4 Gy × 10; b RT stopped early.